Search This Blog

Thursday, July 26, 2007

SUB TENON'S ANECORTAVE ACETATE FOR GLAUCOMA


OSN SuperSite - Preliminary analysis suggests anecortave acetate could
sustained IOP control

According to this review:


Open-angle glaucoma patients treated with a single sub-Tenon injection of anecortave acetate showed a significant, sustained reduction in IOP (average 7.2mmHg) over 3 months, according to an interim analysis of data from a clinical study.

No comments:

Post a Comment

Leave a Comment or Question: